Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Brisson

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the LiteratureMélanie Drolet, Élodie Bénard, Mark Jit, et al.
The Lancet. Global Health|February 28, 2020
Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling studyKaja M Abbas, Kevin van Zandvoort, Marc Brisson, et al.
Eclinicalmedicine|August 2, 2024
Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countriesKiesha Prem, Tania Cernuschi, Stefano Malvolti, et al.
Vaccine|October 14, 2008
Modeling cervical cancer prevention in developed countriesJane J Kim, Marc Brisson, W John Edmunds, et al.
Vaccine|May 27, 2018
Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programsLauri E Markowitz, Melanie Drolet, Norma Perez, et al.
The Journal of Infectious Diseases|February 25, 2016
Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV VaccineHarrell W Chesson, Jean-François Laprise, Marc Brisson, et al.
Australian and New Zealand Journal of Public Health|December 22, 2005
Modelling the impact of vaccination on the epidemiology of varicella zoster virus in AustraliaHeather F Gidding, Marc Brisson, C Raina Macintyre, et al.
The Canadian Journal of Urology|September 24, 2004
An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasiaHeather McDonald, Margaret Hux, Marc Brisson, et al.
Human Vaccines|April 3, 2008
The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgiaMarc Brisson, James M Pellissier, Stéphanie Camden, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 22, 2007
Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infectionMarc Brisson, Nicolas Van de Velde, Philippe De Wals, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 14, 2018
Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the LiteratureMélanie Drolet, Élodie Bénard, Mark Jit, et al.
The Lancet. Global Health|February 28, 2020
Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling studyKaja M Abbas, Kevin van Zandvoort, Marc Brisson, et al.
Eclinicalmedicine|August 2, 2024
Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countriesKiesha Prem, Tania Cernuschi, Stefano Malvolti, et al.
Vaccine|October 14, 2008
Modeling cervical cancer prevention in developed countriesJane J Kim, Marc Brisson, W John Edmunds, et al.
Vaccine|May 27, 2018
Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programsLauri E Markowitz, Melanie Drolet, Norma Perez, et al.
The Journal of Infectious Diseases|February 25, 2016
Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV VaccineHarrell W Chesson, Jean-François Laprise, Marc Brisson, et al.
Australian and New Zealand Journal of Public Health|December 22, 2005
Modelling the impact of vaccination on the epidemiology of varicella zoster virus in AustraliaHeather F Gidding, Marc Brisson, C Raina Macintyre, et al.
The Canadian Journal of Urology|September 24, 2004
An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasiaHeather McDonald, Margaret Hux, Marc Brisson, et al.
Human Vaccines|April 3, 2008
The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgiaMarc Brisson, James M Pellissier, Stéphanie Camden, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 22, 2007
Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infectionMarc Brisson, Nicolas Van de Velde, Philippe De Wals, et al.
Pageof 15